A Phase III Trial to Assess the Efficacy, Acceptability and Safety of Moviprep® Versus a 4L PEG+E Standard Solution
Status:
Completed
Trial end date:
2002-12-01
Target enrollment:
Participant gender:
Summary
The study was carried out as a randomised, single-blind, active-controlled, multi-centric,
phase III study with two parallel treatment groups. The primary efficacy criterion was the
frequency of effective gut cleansing in each of the two treatment groups (grade A or B
"overall quality of gut cleansing" as judged by a blinded expert panel on the basis of
videotapes recorded during the endoscopic procedure).